MNGIE Patient Resource Website

In an innovative partnership, Entrada Therapeutics and Shofsky took on the challenge of demystifying MNGIE (Mitochondrial NeuroGastroIntestinal Encephalopathy), a rare disease, for those most impacted by it. Our collaboration resulted in the creation of MNGIE Connect, a groundbreaking platform designed to make critical information about the disease accessible and understandable to a non-scientific audience. Part of our collaboration also involved designing a logo for MNGIE Connect, encapsulating the essence of the initiative. Through a strategic blend of welcoming design aesthetics, scientifically accurate molecular illustrations, and the latest in lightweight vector video animations, we’ve established a resource that not only educates but provides comfort and understanding to patients, their families, and healthcare providers. MNGIE Connect stands as a testament to our commitment to bridging the gap between complex medical information and the needs of those it affects most, embodying our dedication to innovation, empathy, and clarity.